・リドカノール
Wikipedia preview
出典(authority):フリー百科事典『ウィキペディア(Wikipedia)』「2016/03/17 15:12:34」(JST)
[Wiki en表示]
Polidocanol
|
Systematic (IUPAC) name |
3,6,9,12,15,18,21,24,27-nonaoxanonatriacontan-1-ol
|
Clinical data |
AHFS/Drugs.com |
International Drug Names |
Pregnancy
category |
- Topical: allowed
Injection: contraindication in months 1–3 and after week 36
|
Routes of
administration |
topical, subcutaneous injection |
Legal status |
- OTC (topical), ℞ (injection)
|
Identifiers |
CAS Number |
9002-92-0 Y
3055-99-0 |
ATC code |
C05BB02 (WHO) |
PubChem |
CID 656641 |
ChemSpider |
570993 Y |
UNII |
0AWH8BFG9A N |
KEGG |
D01993 Y |
ChEMBL |
CHEMBL1201751 N |
Synonyms |
- Polydocanol
- Laureth 9
- Macrogol lauryl ether
- Lauromacrogol
- PEG-9 lauryl alcohol
- POE-9 lauryl alcohol
- Dodecylpolyethyleneglycolether
- Hydroxyl polyethoxy dodecane
- Oxypolyethoxydodecane
|
Chemical data |
Formula |
C30H62O10 |
Molar mass |
582.8073 g/mol (predicted) |
SMILES
-
CCCCCCCCCCCCOCCOCCOCCOCCOCCOCCOCCOCCOCCO
|
InChI
-
InChI=1S/C30H62O10/c1-2-3-4-5-6-7-8-9-10-11-13-32-15-17-34-19-21-36-23-25-38-27-29-40-30-28-39-26-24-37-22-20-35-18-16-33-14-12-31/h31H,2-30H2,1H3
-
Key:ONJQDTZCDSESIW-UHFFFAOYSA-N
|
NY (what is this?) (verify) |
Polidocanol is a local anaesthetic and antipruritic component of ointments and bath additives. It relieves itching caused by eczema and dry skin.[1]
The substance is also used as a sclerosant, an irritant injected to treat varicose veins, under the trade names Asclera, Aethoxysklerol[2] and Varithena.[3] Polidocanol causes fibrosis inside varicose veins, occluding the lumen of the vessel, and reducing the appearance of the varicosity.
The FDA has approved polidocanol injections for the treatment of small varicose (less than 1 mm in diameter) and reticular veins (1 to 3 mm in diameter). Polidocanol works by damaging the cell lining of blood vessels, causing them to close and eventually be replaced by other types of tissue.[4][5]
Pure polidocanol for pharmaceutical use
References
- ^ "E45 itch relief cream". netdoctor.co.uk. Retrieved 2007-07-12.
- ^ Sclerotherapy, Laurence Z Rosenberg, MD, eMedicine.com
- ^ "Varithena™ (polidocanol injectable foam) For Intravenous Use. Full Prescribing Information" (PDF). Biocompatibles, Inc. Retrieved 1 October 2015.
- ^ Facts and Companies: Varicose Vein Treatment Approved
- ^ "Asclera Full Prescribing Information in Drug Reference Encyclopedia". Retrieved 2010-04-11.
Vasoprotectives (C05)
|
|
Antihemorrhoidals for topical use |
corticosteroids |
- Hydrocortisone
- Prednisolone
- Betamethasone
- Fluorometholone
- Fluocortolone
- Dexamethasone
- Fluocinolone acetonide
- Fluocinonide
|
|
local anesthetics |
- Lidocaine
- Tetracaine
- Benzocaine
- Dibucaine
- Procaine
- Oxetacaine
- Pramocaine
|
|
other |
|
|
|
Antivaricose therapy |
heparins or heparinoids for topical use |
- Organo-heparinoid
- Sodium apolate
- Heparin
- Pentosan polysulfate
|
|
sclerosing agents for local injection |
- Monoethanolamine oleate
- Polidocanol
- Inverted sugar syrup
- Sodium tetradecyl sulfate
- Phenol
|
|
other |
|
|
|
Capillary stabilising agents |
bioflavonoids |
- Rutoside
- Monoxerutin
- Diosmin
- Troxerutin
- Hidrosmin
|
|
other |
|
|
|
UpToDate Contents
全文を閲覧するには購読必要です。 To read the full text you will need to subscribe.
English Journal
- The long-term efficacy of hydrocele treatment with aspiration and sclerotherapy with polidocanol compared to placebo: a prospective, double-blind, randomized study.
- Lund L1, Kloster A2, Cao T2.Author information 1Department of Urology, Odense University Hospital, Odense, Denmark; Viborg Hospital, Viborg, Denmark. Electronic address: Lars.Lund@rsyd.dk.2Viborg Hospital, Viborg, Denmark.AbstractPURPOSE: We evaluate whether aspiration and sclerosing of hydrocele testis is an effective treatment.
- The Journal of urology.J Urol.2014 May;191(5):1347-50. doi: 10.1016/j.juro.2013.11.025. Epub 2013 Nov 18.
- PURPOSE: We evaluate whether aspiration and sclerosing of hydrocele testis is an effective treatment.MATERIALS AND METHODS: Men with symptomatic hydrocele testis were included in this prospective, double-blind, randomized study with polidocanol and placebo. Patients were randomized to active treatme
- PMID 24262498
- The VANISH-2 study: a randomized, blinded, multicenter study to evaluate the efficacy and safety of polidocanol endovenous microfoam 0.5% and 1.0% compared with placebo for the treatment of saphenofemoral junction incompetence.
- Todd KL 3rd1, Wright D; the VANISH-2 Investigator Group.Author information 1Southeast Vein and Laser Center, Dothan, AL, USA.AbstractOBJECTIVE: To determine efficacy and safety of polidocanol endovenous microfoam in treatment of symptoms and appearance in patients with saphenofemoral junction incompetence due to reflux of the great saphenous vein or major accessory veins.
- Phlebology / Venous Forum of the Royal Society of Medicine.Phlebology.2014 Apr 14. [Epub ahead of print]
- OBJECTIVE: To determine efficacy and safety of polidocanol endovenous microfoam in treatment of symptoms and appearance in patients with saphenofemoral junction incompetence due to reflux of the great saphenous vein or major accessory veins.METHOD: Patients were randomized equally to receive polidoc
- PMID 23864535
- Combination therapy of hyaluronic acid mesotherapic injections and sclerotherapy for treatment of lower leg telangiectasia without major venous insufficiency: a preliminary clinical study.
- Iannitti T1, Rottigni V, Torricelli F, Palmieri B.Author information 11Department of Physiology, School of Medicine, University of Kentucky Medical Center, Lexington, KY, USA.AbstractBACKGROUND: Telangiectasia is the dilation of dermal capillaries mainly due to hypertension and vein insufficiency. Treatments of choice for this condition are sclerotherapy with foam liquid or intradermal fiber optic laser energy delivery.
- Clinical and applied thrombosis/hemostasis : official journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis.Clin Appl Thromb Hemost.2014 Apr;20(3):326-30. doi: 10.1177/1076029612461844. Epub 2012 Oct 17.
- BACKGROUND: Telangiectasia is the dilation of dermal capillaries mainly due to hypertension and vein insufficiency. Treatments of choice for this condition are sclerotherapy with foam liquid or intradermal fiber optic laser energy delivery.AIM: The aim of this study was to assess the efficacy of a n
- PMID 23076772
Japanese Journal
- ポリドカノールによる硬化療法を行った口腔内血管腫の1例
- 橘 寛彦,吉田 孝史,石川 恵生 [他]
- 日本口腔外科学会雑誌 = Japanese journal of oral and maxillofacial surgery 58(11), 660-664, 2012-11
- NAID 40019499495
- 大伏在静脈本幹のエコーガイド下フォーム硬化療法の有用性について
- 久米 博子,佐藤 彰治,藤田 聡子,加賀山 知子,岩井 武尚
- 静脈学 23(1), 1-5, 2012-02-25
- … Foam sclerosant was made by Tessari method, consist of 3%Polidocanol and CO2 in the proportion of 1 : 3. …
- NAID 10030353035
Related Links
- Click here to find out more about Asclera. ... Indication: Asclera ® (polidocanol) Injection is a prescription medicine that is used in a procedure called sclerotherapy to remove unwanted veins on your legs.
- >Polidocanol(CAS 3055-99-0)がPRTR法の1-407 "ポリ(オキシエチレン)=アルキルエーテル >(アルキル基の炭素数が12から15までのもの及びその混合物に限る。)" >に該当するかどうかについて教えていただけます ...
Related Pictures
★リンクテーブル★
[★]
- 英
- polidocanol
- 同
- ポリエチレングリコールモノドデシルエーテル polyethylene glycol monododecyl ether
- 商
- エトキシスクレロール Aethoxysklerol、ポリドカスクレロール
- 関
- 食道静脈瘤、静脈瘤
- 止血剤